Journal Article DKFZ-2026-00833

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Head-to-head comparison of the diagnostic value of fecal and serum carcinoembryonic antigen for colorectal cancer detection.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Wiley-Liss Bognor Regis

International journal of cancer nn, nn () [10.1002/ijc.70435]
 GO

Abstract: This study aimed to conduct a head-to-head comparison of the diagnostic value of serum carcinoembryonic antigen (sCEA) and fecal CEA (fCEA) for colorectal cancer (CRC) detection. Fecal and serum samples from 80 CRC cases at various tumor stages and 100 controls free of colorectal neoplasms at screening colonoscopy were randomly selected from two ongoing large prospective CRC detection studies (IDA and BLITZ) for CEA measurements. Fecal samples were processed using two methods: with and without mechanical homogenization. Diagnostic performance (area under the curve value [AUC], sensitivity) of fCEA and sCEA was compared individually and in combination with fecal immunochemical test (FIT). The fCEA concentrations obtained using both sample processing methods were highly correlated in both CRC cases and controls, but neither correlated with sCEA. The sCEA concentrations demonstrated significantly greater differences between the CRC and control group compared to fCEA concentrations. The diagnostic performance of fCEA obtained with both fecal sample processing methods was significantly lower than that of sCEA (AUC: 0.62 and 0.57 vs. 0.83, both p < .001; sensitivity at 85% specificity: 36.2% and 26.2% vs. 52.5%, p = .067 and .002). Algorithms combining sCEA with fCEA did not significantly improve the diagnostic performance compared to sCEA alone. Combining FIT with sCEA improved diagnostic performance over FIT alone. However, combining FIT with fCEA showed no improvement. In conclusion, fCEA is inferior to sCEA as a non-invasive biomarker for CRC detection. Combination of FIT with sCEA demonstrates greater potential for CRC screening than combination of FIT with fCEA.

Keyword(s): biomarker ; carcinoembryonic antigen ; colorectal cancer ; detection

Classification:

Note: #EA:C070#LA:C070#LA:M320# / epub

Contributing Institute(s):
  1. C070 Klinische Epidemiologie der Krebsfrüherkennung (C070)
  2. Primäre Krebsprävention (C120)
  3. Koordinierungsstelle der Cancer Prevention GS (M320)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-04-10, last modified 2026-04-10



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)